Metropolitan Health Networks
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Metropolitan Health Networks missed slightly on revenues and whiffed on earnings per share.
Compared to the prior-year quarter, revenue increased significantly and GAAP earnings per share shrank significantly.
Gross margins improved, operating margins increased, net margins shrank.
Metropolitan Health Networks reported revenue of $175.1 million. The two analysts polled by S&P Capital IQ expected to see net sales of $178.1 million on the same basis. GAAP reported sales were 92% higher than the prior-year quarter's $91.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.13. The two earnings estimates compiled by S&P Capital IQ predicted $0.19 per share on the same basis. GAAP EPS of $0.06 for Q4 were 57% lower than the prior-year quarter's $0.14 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 24.2%, 590 basis points better than the prior-year quarter. Operating margin was 14.0%, 310 basis points better than the prior-year quarter. Net margin was 1.6%, 500 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $200.4 million. On the bottom line, the average EPS estimate is $0.25.
Next year's average estimate for revenue is $781.5 million. The average EPS estimate is $0.86.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 220 members out of 232 rating the stock outperform, and 12 members rating it underperform. Among 37 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 33 give Metropolitan Health Networks a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Metropolitan Health Networks is buy, with an average price target of $8.71.
Over the decades, small-cap stocks, like Metropolitan Health Networks have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Metropolitan Health Networks to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy
More from The Motley Fool
Metropolitan Health Networks Beats Analyst Estimates on EPS
Just the facts, Fool.
Metropolitan Health Networks Increases Sales but Misses Estimates on Earnings
Just the facts, Fool.
Can Metropolitan Health Networks Beat These Numbers?